DYPER Awarded “Disposable Diaper Product of the Year” In 2024 Baby Innovation Program
25 juil. 2024 08h00 HE
|
Baby Innovation Awards
LOS ANGELES, July 25, 2024 (GLOBE NEWSWIRE) -- Charcoal Enhanced diapers from DYPER are the brand’s most natural, protective diapers, offering maximum absorbency and leak protection to prevent rash...
Cummins Joins SDVerse as a Premier Partner of its One-of-a-Kind Automotive Software Marketplace
24 juil. 2024 13h00 HE
|
SDVerse
DETROIT, July 24, 2024 (GLOBE NEWSWIRE) -- SDVerse, a marketplace for buyers and sellers of automotive software, on July 24th, 2024, announced that global power technology leader Cummins Inc. has...
Itron Invites Nominations for 2024 Innovator Award
23 juil. 2024 08h45 HE
|
Itron, Inc.
Award recognizes Itron customers for implementing cutting-edge solutions with Itron’s partner program
Oxford BioTherapeutics Named Best Tech SME of the Year at Thames Valley Tech & Innovation Awards 2024
22 juil. 2024 08h00 HE
|
Oxford BioTherapeutics
Oxford, UK and San Jose, California, 22 July 2024 - Oxford BioTherapeutics (OBT), a clinical stage oncology company with a pipeline of immuno-oncology and Antibody Drug Conjugate (ADC)-based...
Santiago Calatrava and John Zils to Receive 2024 Lifetime Achievement Awards from Council on Tall Buildings and Urban Habitat
18 juil. 2024 11h00 HE
|
The Council on Tall Buildings and Urban Habitat
Chicago, July 18, 2024 (GLOBE NEWSWIRE) -- The Council on Tall Buildings and Urban Habitat (CTBUH) today announced the winner of its 2024 Lynn S. Beedle Lifetime Achievement Award: Santiago...
Itron Celebrates More Than 1 Million Cyble™ 5 Communication Modules Shipped
18 juil. 2024 08h45 HE
|
Itron, Inc.
Severn Trent Water receives milestone module as part of project to improve consumer engagement and improve leak detection.
First half of 2024: Boehringer Ingelheim progresses pipeline at pace and reaches major milestones
18 juil. 2024 03h05 HE
|
Boehringer Ingelheim
Milestones reached in cardiovascular, renal, metabolic health (CRM), and oncologyFurther data read-outs expected in 2024 in oncology, mental health, and pulmonary fibrosisStrong first half net sales...
Novartis erzielt im zweiten Quartal weiterhin kräftige Umsatzsteigerungen und erhöht die Kerngewinnmarge; Gewinnprognose für das Geschäftsjahr 2024 angehoben
18 juil. 2024 01h00 HE
|
Novartis Pharma AG
Ad-hoc-Mitteilung gemäss Art. 53 KRDer Nettoumsatz wuchs im zweiten Quartal um +11% (kWk1, +9% USD), das operative Kernergebnis verbesserte sich um +19% (kWk, +17% USD) Das Umsatzwachstum...
Novartis a poursuivi au T2 la forte croissance de son chiffre d’affaires et l’expansion de sa marge core; hausse des prévisions de son résultat opérationnel core pour 2024
18 juil. 2024 01h00 HE
|
Novartis Pharma AG
Annonce événementielle au sens de l’art. 53 RCRésultats du deuxième trimestre (T2)Chiffre d’affaires net en hausse de +11% (tcc1, +9% USD) et du résultat opérationnel core, de +19% (tcc, +17% USD) La...
Novartis continues to deliver strong sales growth and core margin expansion in Q2; raises FY 2024 bottom-line guidance
18 juil. 2024 01h00 HE
|
Novartis Pharma AG
Ad hoc announcement pursuant to Art. 53 LRQ2 net sales grew +11% (cc1, +9% USD) with core operating income up +19% (cc, +17% USD) Sales growth driven by continued strong performance from Entresto...